|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7000 AUD | +0.72% |
|
-0.71% | -4.76% |
| 20/05 | Monash IVF appoints Fleur Cattrall as inaugural Chief Medical Officer | RE |
| 20/05 | Monash IVF Group Appoints Chief Medical Officer | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Hospitals and Healthcare Centers | ||||||||||
Healthcare Facilities & Services | 18Cr | 19Cr | 21Cr | 26Cr | 27Cr | |||||
Total Assets | 35Cr | 38Cr | 42Cr | 51Cr | 49Cr | |||||
Interest Expense | -24.52L | -21.51L | -33.04L | -53.68L | -73.9L | |||||
Income Tax Expense | 1.04Cr | 77.2L | 78.73L | -47.07L | 1.04Cr | |||||
CAPEX | -1Cr | -1.18Cr | -2.78Cr | -2.08Cr | -1.24Cr | |||||
EBT | 3.59Cr | 2.62Cr | 2.98Cr | -1.07Cr | 3.61Cr | |||||
D&A | 1.07Cr | 1.24Cr | 1.29Cr | 1.64Cr | 1.99Cr | |||||
Operating Income | 3.84Cr | 2.84Cr | 3.31Cr | -53.44L | 4.34Cr | |||||
Net Income | 2.51Cr | 1.84Cr | 2.18Cr | -65.27L | 2.5Cr |
Geographical Revenue Distribution History
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Australia | 17Cr | 18Cr | 20Cr | 24Cr | 25Cr | |||||
Total Assets | 34Cr | 37Cr | 41Cr | 49Cr | 48Cr | |||||
Interest Expense | -23.5L | -21.1L | -32.52L | -53.41L | -70.83L | |||||
Income Tax Expense | 93.99L | 70.62L | 70.75L | - | - | |||||
D&A | 1.23Cr | 1.41Cr | 1.43Cr | 1.8Cr | 2.03Cr | |||||
CAPEX | -99.16L | -1.18Cr | -4.84Cr | - | - | |||||
Net Income | 2.24Cr | 1.7Cr | 2.1Cr | - | - | |||||
EBT | 3.18Cr | 2.41Cr | 2.81Cr | -1.38Cr | 3.39Cr | |||||
Operating Income | 3.41Cr | 3.06Cr | 3.62Cr | 4.02Cr | 4Cr | |||||
EBITDA | - | - | - | 5.91Cr | 6.15Cr | |||||
International | 1.07Cr | 1.02Cr | 1.28Cr | 1.64Cr | 1.85Cr | |||||
Total Assets | 1.39Cr | 1.55Cr | 1.61Cr | 1.51Cr | 1.6Cr | |||||
Interest Expense | -1L | -37T | -27T | 29T | -2L | |||||
Income Tax Expense | 10.36L | 7L | 8L | - | - | |||||
D&A | 6L | 7L | 10.06L | 6L | 16.75L | |||||
CAPEX | -1L | -5L | -13.45L | - | - | |||||
Net Income | 31.09L | 14.88L | 9L | - | - | |||||
EBT | 41.45L | 21.46L | 17.16L | 31.04L | 22.39L | |||||
Operating Income | 42.46L | 28.31L | 18.96L | 30.75L | 29.85L | |||||
EBITDA | - | - | - | 36.79L | 48.81L |
- Stock Market
- Stocks
- MVF Stock
- Financials Monash IVF Group Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















